Literature DB >> 23110460

Aminoglycoside antibiotics in the 21st century.

Bernd Becker1, Matthew A Cooper.   

Abstract

Aminoglycoside antibiotics were among the first antibiotics discovered and used clinically. Although they have never completely fallen out of favor, their importance has waned due to the emergence of other broad-spectrum antibiotics with fewer side effects. Today, with the dramatically increasing rate of infections caused by multidrug-resistant bacteria, focus has returned to aminoglycoside antibiotics as one of the few remaining treatment options, particularly for Gram-negative pathogens. Although the mechanisms of resistance are reasonably well understood, our knowledge about the mode of action of aminoglycosides is still far from comprehensive. In the face of emerging bacterial infections that are virtually untreatable, it is time to have a fresh look at this old class to reinvigorate the struggle against multidrug-resistant pathogens.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23110460     DOI: 10.1021/cb3005116

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  91 in total

1.  Heterologous Expression and Functional Characterization of the Exogenously Acquired Aminoglycoside Resistance Methyltransferases RmtD, RmtD2, and RmtG.

Authors:  Laís L Corrêa; Marta A Witek; Natalia Zelinskaya; Renata C Picão; Graeme L Conn
Journal:  Antimicrob Agents Chemother       Date:  2015-11-09       Impact factor: 5.191

2.  C3'-Deoxygenation of Paromamine Catalyzed by a Radical S-Adenosylmethionine Enzyme: Characterization of the Enzyme AprD4 and Its Reductase Partner AprD3.

Authors:  Hak Joong Kim; Jake LeVieux; Yu-Cheng Yeh; Hung-Wen Liu
Journal:  Angew Chem Int Ed Engl       Date:  2016-02-16       Impact factor: 15.336

3.  Effects of the 1- N-(4-Amino-2 S-hydroxybutyryl) and 6'- N-(2-Hydroxyethyl) Substituents on Ribosomal Selectivity, Cochleotoxicity, and Antibacterial Activity in the Sisomicin Class of Aminoglycoside Antibiotics.

Authors:  Amr Sonousi; Vikram A Sarpe; Margarita Brilkova; Jochen Schacht; Andrea Vasella; Erik C Böttger; David Crich
Journal:  ACS Infect Dis       Date:  2018-05-10       Impact factor: 5.084

4.  Simultaneous elucidation of antibiotic mechanism of action and potency with high-throughput Fourier-transform infrared (FTIR) spectroscopy and machine learning.

Authors:  Bernardo Ribeiro da Cunha; Luís P Fonseca; Cecília R C Calado
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-14       Impact factor: 4.813

5.  Detection and Quantification of Ribosome Inhibition by Aminoglycoside Antibiotics in Living Bacteria Using an Orthogonal Ribosome-Controlled Fluorescent Reporter.

Authors:  Shijie Huang; Xuechen Zhu; Charles E Melançon
Journal:  ACS Chem Biol       Date:  2015-11-04       Impact factor: 5.100

6.  New trends in aminoglycosides use.

Authors:  Marina Y Fosso; Yijia Li; Sylvie Garneau-Tsodikova
Journal:  Medchemcomm       Date:  2014-08-01       Impact factor: 3.597

7.  N6', N6''', and O4' Modifications to Neomycin Affect Ribosomal Selectivity without Compromising Antibacterial Activity.

Authors:  Girish C Sati; Dimitri Shcherbakov; Sven N Hobbie; Andrea Vasella; Erik C Böttger; David Crich
Journal:  ACS Infect Dis       Date:  2017-04-06       Impact factor: 5.084

8.  A review of patents (2011-2015) towards combating resistance to and toxicity of aminoglycosides.

Authors:  Nishad Thamban Chandrika; Sylvie Garneau-Tsodikova
Journal:  Medchemcomm       Date:  2015-11-19       Impact factor: 3.597

9.  Endless Resistance. Endless Antibiotics?

Authors:  Jed F Fisher; Shahriar Mobashery
Journal:  Medchemcomm       Date:  2015-11-03       Impact factor: 3.597

Review 10.  The evolving role of chemical synthesis in antibacterial drug discovery.

Authors:  Peter M Wright; Ian B Seiple; Andrew G Myers
Journal:  Angew Chem Int Ed Engl       Date:  2014-07-02       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.